Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
MIS-C "is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. This rampant inflammation has been recorded in multiple organ systems; yet, clinical research into the pathogenesis of the disease is insufficient. However, we know that many children with MIS-C were exposed or infected with SARS-CoV-2. Currently, the lack of a universal case definition of MIS-C has limited the number of cases that are accurately diagnosed and hampered with proper treatment of the disease. Further research into the clinical, epidemiological and immunological nature of MIS-C is desperately needed. MIS-C can be serious, even deadly, but most children who were diagnosed with this condition have gotten better with medical care."
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
Abstract for An analysis of SARS-CoV-2 viral load by patient age
References for Children's Symptomatic COVID-19 Infection by Journal/Source
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Hyperinflammatory shock in children during COVID-19 pandemic
Comparing Kawasaki Disease (KD) and MIS-C
Comparison of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 With Other Childhood Inflammatory Diseases
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
Secondary Haemophagocytic Lymphiohistocytosis and COVID-19
Hyperinflammatory shock in children with family exposure to COVID-19
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19
Vascular Hyperpemeability and Multi-organ failure in COVID-19
Secondary haemophagocytic lymphohistiocytosis (sHLH) and COVID-19
Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Cytokine Release Syndrome and COVID-19
COVID-19-Associated Hyperinflammation
Learn After
References for Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 by Journal/Source
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 Organized by Country
Symptoms of MIS-C According to Centers for Disease Control and Prevention
Emergency Warning Signs of MIS-C According to the Centers for Disease Control and Prevention
Clinical spectrum of COVID-19 and COVID-19-associated Multisystem Inflammatory Syndrome in Children (MIS-C)
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
Systematic Review of 953 MIS-C Cases
Comorbidies/Social Determinants of Health Present in MIS-C Patients